Management of microcarcinomas (papillary and medullary) of the thyroid

被引:24
作者
Wu, Leslie S. [1 ]
Milan, Stacey A. [2 ]
机构
[1] Maine Med Ctr, Dept Surg, Portland, ME 04102 USA
[2] Thomas Jefferson Univ Hosp, Dept Surg, Philadelphia, PA 19107 USA
关键词
clinical outcome; medullary thyroid carcinoma; neck dissection; papillary thyroid carcinoma; papillary thyroid microcarcinoma; thyroidectomy; SERUM CALCITONIN; UNITED-STATES; FOLLOW-UP; CANCER; MUTATIONS; CARCINOMA; RISK; PREVALENCE; GUIDELINES; EXPERIENCE;
D O I
10.1097/CCO.0b013e328359feea
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Microcarcinomas of the thyroid gland are defined by the size criteria as tumors measuring less than 1 cm in greatest dimension. The clinical significance of papillary thyroid microcarcinoma (PTMC) and medullary thyroid microcarcinoma (MTMC) is debatable. Variation in practice patterns exist in the United States with regard to diagnosis, treatment, and long-term management. We review the most recent guidelines on the management of these controversial malignancies. Recent findings PTMC has recently been shown to be the most common thyroid malignancy in patients older than 45 years in the United States. The management of patients with PTMC is not well defined, although recent studies have indicated that total or near-total thyroidectomy decreases overall recurrence rate. BRAF(V600E) mutation testing plays an increasingly important role in perioperative management and has potential for targeted molecular therapies. Prophylactic thyroidectomy is indicated early in life for RET mutation carriers at risk for medullary thyroid cancer. New evidence suggests that timing may be personalized based on specific exon mutations and serum calcitonin levels. The biological significance and surgical management of MTMC have been debated, but the most recent studies indicate a relatively high incidence of lymph node metastases, distant metastases, and persistently elevated postoperative calcitonin; and argue for the aggressive management of even the smallest MTMCs. Summary Total or near-total thyroidectomy is the treatment of choice in patients with PTMC in order to eradicate multifocal disease and decrease overall recurrence rate. If there are palpable, biopsy-proven, or grossly apparent metastases at the time of operation, central lymphadenectomy should be performed. Prophylactic thyroidectomy in hereditary cases of MTMC may be guided by knowledge of specific exon mutations and calcitonin levels. The extent of operation for both hereditary and sporadic MTMC is nonstandardized, and further studies are needed to clarify this issue.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
[1]  
[Anonymous], CYTOPATHOLOGY
[2]   Microcarcinoma of the thyroid [J].
Baloch, ZW ;
LiVolsi, VA .
ADVANCES IN ANATOMIC PATHOLOGY, 2006, 13 (02) :69-75
[3]   Mild hypercalcitoninaemia and sporadic thyroid disease [J].
Cherenko, M. ;
Slotema, E. ;
Sebag, F. ;
De Micco, C. ;
Henry, J. F. .
BRITISH JOURNAL OF SURGERY, 2010, 97 (05) :684-690
[4]   Calcitonin measurement in the evaluation of thyroid nodules in the United States: A cost-effectiveness and decision analysis [J].
Cheung, Kevin ;
Roman, Sanziana A. ;
Wang, Tracy S. ;
Walker, Hugh D. ;
Sosa, Julie Ann .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06) :2173-2180
[5]   Ultrasonographic findings of medullary thyroid cancer: differences according to tumor size and correlation with fine needle aspiration results [J].
Choi, Nami ;
Moon, Won-Jin ;
Lee, Jeong Hyun ;
Baek, Jung Hwan ;
Kim, Dong Wook ;
Park, Sun-Won .
ACTA RADIOLOGICA, 2011, 52 (03) :312-316
[6]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214
[7]  
Creach KM, 2012, ISRN ENDOCRINOL, V2012
[8]   Screening for Medullary Thyroid Carcinoma with Serum Calcitonin Measurements in Patients with Thyroid Nodules in the United States and Canada [J].
Daniels, Gilbert H. .
THYROID, 2011, 21 (11) :1199-1207
[9]   Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas [J].
Durante, Cosimo ;
Attard, Marco ;
Torlontano, Massimo ;
Ronga, Giuseppe ;
Monzani, Fabio ;
Costante, Giuseppe ;
Ferdeghini, Marco ;
Tumino, Salvatore ;
Meringolo, Domenico ;
Bruno, Rocco ;
De Toma, Giorgio ;
Crocetti, Umberto ;
Montesano, Teresa ;
Dardano, Angela ;
Lamartina, Livia ;
Maniglia, Adele ;
Giacomelli, Laura ;
Filetti, Sebastiano .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (11) :4882-4888
[10]   Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders [J].
Elisei, R ;
Bottici, V ;
Luchetti, F ;
Di Coscio, G ;
Romei, C ;
Grasso, L ;
Miccoli, P ;
Iacconi, P ;
Basolo, F ;
Pinchera, A ;
Pacini, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :163-168